TrademarkOpen
Search / US trademark / 99293609
US trademark / service mark

CYMONALL

Allowed — statement of use stage
First Extension - Granted

Status timeline

  1. 21 Jul 2025
    Application filed
    New Application Entered
  2. 8 Dec 2025
    Assigned to an examining attorney
    Assigned To Examiner
  3. 9 Dec 2025
    Approved for publication
    Approved For Pub - Principal Register
  4. 6 Jan 2026
    Published for opposition
    Published For Opposition
  5. 3 Mar 2026
    Notice of allowance issued — statement of use required
    Noa E-Mailed - Sou Required From Applicant
  6. 26 Aug 2026
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
All 13 USPTO events
2026-08-27Notice Of Approval Of Extension Request E-Mailed
2026-08-26Sou Teas Extension Received
2026-08-26Sou Extension 1 Filed
2026-08-26Sou Extension 1 Granted
2026-03-03Noa E-Mailed - Sou Required From Applicant
2026-01-06Published For Opposition
2026-01-06Official Gazette Publication Confirmation E-Mailed
2025-12-31Notification Of Notice Of Publication E-Mailed
2025-12-09Approved For Pub - Principal Register
2025-12-08Assigned To Examiner
2025-11-25New Application Office Supplied Data Entered
2025-07-21New Application Entered
2025-07-21Application Filing Receipt Mailed

Goods & services

Class 9 Software, electronics & scientific

Downloadable computer software for use in the management, detection, analysis, mitigation, and resolution of security vulnerabilities and threats in the field of cyber security

Class 42 Technology & SaaS

Software as a service (SAAS) services featuring software for use in the management, detection, analysis, mitigation, and resolution of security vulnerabilities and threats in the field of cyber security

Source & freshness

Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 27 Aug 2026; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.